Table 4.

Univariable Linear Regression (N = 51)

	Simple Linear Regressions Response Variable:
	Individual Change in Global Health Status at 12-Month Follow-upa		Individual Change in Fatigue Score at 12-Month Follow-upb
Predictor Variables	B 95% CI	P-value	B 95% CI	P-value
Age at surgery	−0.3, 0.9	.27	−1,1, 0.1	.10
Sex, female	−20.6, 7.9	.37	−11.7, 17.2	.70
KPS < 80 at admission	−32.6, 11.5	.34	−7.1, 37.0	.18
History of seizures at admission	−14.0, 16,4	.87	−21.6, 8.9	.41
Choice of neurosurgical intervention, resection	−17.4, 43.1	.85	−40.7, 20.6	.51
Tumor type, oligodendroglioma	−3.4, 24.7	.13	−21.6, 7.1	.31
Tumor grade, grade 2	−7.6, 22.1	.33	−4.7, 25.0	.18
No postoperative treatment before 12-month follow-up	−1.3, 36.8	.07	−16.9, 22.1	.76
Chemotherapy only before 12-month follow-up,	−37.2, 10.4	.26	2.0, 48.6	.03
Radiochemotherapy before 12-month follow-up,	−22.5, 10.2	.46	−30.0, 2.3	.09
Antiepileptic drug use at 12-month follow-up	−5.9, 27.4	.20	−35.3, −2.5	.03
Any permanent, new or worsened, neurological deficit up to 3-month follow-up	−0.3, 32.3	.05	−21.0, 13.1	.64

^aIn individual change in global health status negative values indicate improvement.

^bIn individual change in fatigue score positive values indicate improvement.